Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

"Seeing" in NARCOMS: a look at vision-related quality of life in the NARCOMS registry.
T cells from autoimmune patients display reduced sensitivity to immunoregulation by mesenchymal stem cells: Role of IL-2.
Mast cells on the mind: new insights and opportunities.
Neuro-Ophthalmic Syndromes and Processing Speed in Multiple Sclerosis.
[Does interferon beta slow the progression of multiple sclerosis? - Long-term effect of IFN-β on progression of physical disability is still not proven].
[Natalizumab in the treatment of patients with relapsing-remitting multiple sclerosis: the preliminary results of the observational program "Sovet"]
[Therapeutic strategy for CIDP (chronic inflammatory demyelinating polyneuropathy)].
Multiple sclerosis deep grey matter: the relation between demyelination, neurodegeneration, inflammation and iron.
Multiple Sclerosis State of the Art (SMART): A Qualitative and Quantitative Analysis of Therapy's Adherence, Hospital Reliability's Perception, and Services Provided Quality.
MOG-IgG in neuromyelitis optica.
Validity of the RAI-MDS for ascertaining diabetes and comorbid conditions in long-term care facility residents.
Mobility, Walking And Physical Activity In Persons With Multiple Sclerosis.
Dietary interventions for multiple sclerosis.
Successful treatment for neuromyelitis optica with systemic lupus erythematosus.
Promotion of remyelination by adipose mesenchymal stem cell transplantation in a cuprizone model of multiple sclerosis.
Central nervous system aquaporin-4 autoimmunity presenting with an isolated cerebral abnormality.
Depressive Symptoms in Multiple Sclerosis from an In Vivo Study with TBSS.
Multiple Sclerosis and Fracture.
Neurobehavioral disorders.
Diffusivity signatures characterize trigeminal neuralgia associated with multiple sclerosis.
Neuromuscular electrical stimulation cycling exercise for persons with advanced multiple sclerosis.
Recombinant human PDCD5 (rhPDCD5) protein is protective in a mouse model of multiple sclerosis.
Confronting Patients About Insufficient Effort: The Impact on Subsequent Symptom Validity and Memory Performance.
Pathophysiology of immune-mediated demyelinating neuropathies - Part II: Neurology.
Microsomal prostaglandin E synthase-1 aggravates inflammation and demyelination in a mouse model of multiple sclerosis.

Pages